Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2023-05-09 6:35:24 am | Novavax Layoffs 2023: What to Know About the Latest NVAX Job Cuts | InvestorPlace |
| 2023-05-08 5:35:0 pm | Lexaria Bioscience Announces Pricing of $2.0 Million Public Offering | ACCESSWIRE |
| 2023-05-08 6:5:0 am | Lexaria’s Human Clinical Nicotine Study Completes Dosing as Planned | ACCESSWIRE |
| 2023-04-24 6:0:0 am | Lexaria Awards CRO Contract for Upcoming U.S. Phase 1b Hypertension Study | ACCESSWIRE |
| 2023-04-20 6:0:0 am | Lexaria is Receiving Four New Patents | ACCESSWIRE |
| 2023-04-20 2:40:0 am | LEXX: DehydraTECH CBD May Offer New Mechanism of Action | Zacks Small Cap Research |
| 2023-03-07 2:54:12 am | Is Lexaria Bioscience (NASDAQ:LEXX) In A Good Position To Deliver On Growth Plans? | Simply Wall St. |
| 2023-03-02 5:45:0 am | Lexaria's DehydraTECH-CBD Diabetes Study Demonstrates Weight Loss, Improved Triglyceride and Cholesterol Levels | ACCESSWIRE |
| 2023-02-21 6:0:0 am | Lexaria Discovers Potential Novel Mechanism From Hypertension Study HYPER-H21-4 | ACCESSWIRE |
Please consider a small donation if you think this website provides you with relevant information